Moderna beefs up COVID-19 vaccine manufacturing for 2021-22

Coronavirus

Workers unload a shipment of Moderna COVID-19 vaccines at the FedEx hub in Toronto, Wednesday, April 28, 2021. (Cole Burston/The Canadian Press via AP)

CAMBRIDGE, Mass. (AP) — Moderna announced Thursday it is beefing up global manufacturing of its COVID-19 vaccine in an effort to produce up to 3 billion doses in 2022.

The company predicts supplying between 800 million and 1 billion doses worldwide this year. But it’s looking ahead as much of the world still will need a first round of COVID-19 vaccinations next year — and to be ready if and when people may need a booster shot.

Moderna’s vaccine is authorized for use by adults in the U.S., European Union and multiple other countries. The company expects data soon from a U.S. study of the two-dose vaccine in 12- to 17-year-olds, and has begun testing the shots in younger children.

Also underway are studies of doses tweaked to better match a worrisome mutated version of the coronavirus.

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Don't Miss

More Don't Miss

Coronavirus News

More Coronavirus

Trending Stories

Your Local Election HQ

More Election

Local Sports

HS Football: Fond du Lac runs away from Kimberly; De Pere, Omro finish unbeaten

Blizzard win 49-29 over Xtreme

Small Springs, Big Fish: Billy Schrauth garnering blue-chip interest

Bay Port and Notre Dame advance to boys soccer spring sectional semifinals

De Pere Girls Cross Country

Northeast Wisconsin natives Dietzen, Heim get shot as undrafted free agents